Solventum Corp financial data

Symbol
SOLV on NYSE
Industry
Surgical & Medical Instruments & Apparatus
Location
C/O 3 M Company, 3 M Center, Building 275 6 W 02, St. Paul, MN
State of incorporation
Delaware
Fiscal year end
December 31
Former names
3M Health Care Co (to 2/9/2024)
Latest financial report
10-Q - Q2 2024 - Aug 9, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 173M shares
Common Stock, Shares, Outstanding 173M shares
Common Stock, Value, Issued 2M USD
Weighted Average Number of Shares Outstanding, Basic 173M shares +0.29%
Weighted Average Number of Shares Outstanding, Diluted 174M shares +0.46%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.08B USD +0.24%
Research and Development Expense 192M USD -0.52%
Costs and Expenses 1.84B USD +10.7%
Operating Income (Loss) 244M USD -41.5%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 96M USD -76.8%
Income Tax Expense (Benefit) 7M USD -92.4%
Net Income (Loss) Attributable to Parent 89M USD -72.3%
Earnings Per Share, Basic 0.51 USD/shares -72.6%
Earnings Per Share, Diluted 0.51 USD/shares -72.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 897M USD
Accounts Receivable, after Allowance for Credit Loss, Current 1.03B USD
Inventory, Net 899M USD
Other Assets, Current 250M USD
Assets, Current 3.36B USD
Property, Plant and Equipment, Net 1.54B USD
Intangible Assets, Net (Excluding Goodwill) 2.72B USD
Goodwill 6.45B USD
Other Assets, Noncurrent 507M USD
Assets 14.6B USD
Accounts Payable, Current 495M USD
Employee-related Liabilities, Current 198M USD
Accrued Liabilities, Current 611M USD
Contract with Customer, Liability, Current 505M USD
Liabilities, Current 2.57B USD
Deferred Income Tax Liabilities, Net 214M USD
Other Liabilities, Noncurrent 305M USD
Liabilities 11.7B USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -943M USD
Retained Earnings (Accumulated Deficit) 89M USD
Stockholders' Equity Attributable to Parent 2.87B USD -75.6%
Liabilities and Equity 14.6B USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 442M USD -13.2%
Net Cash Provided by (Used in) Financing Activities 462M USD
Net Cash Provided by (Used in) Investing Activities -102M USD -56.9%
Common Stock, Shares Authorized 750M shares
Common Stock, Shares, Issued 173M shares
Common Stock, Par or Stated Value Per Share 0.01 USD/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 802M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 897M USD +2200%
Deferred Tax Assets, Valuation Allowance 21M USD
Depreciation 40M USD +17.6%
Payments to Acquire Property, Plant, and Equipment 102M USD +56.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 101M USD -70.6%
Property, Plant and Equipment, Gross 3.47B USD
Deferred Income Tax Expense (Benefit) -25M USD +26.5%
Additional Paid in Capital 3.72B USD
Amortization of Intangible Assets 86M USD -6.52%
Depreciation, Depletion and Amortization 139M USD -4.14%
Share-based Payment Arrangement, Expense 56M USD +600%